A new study gives insight into how cancer immunotherapies might one day be delivered directly to the brain in order to treat brain tumors. The study demonstrated that a new type of nano-immunotherapy traversed the blood-brain barrier in laboratory mice, inducing a local immune response in brain tissue surrounding the tumors. The tumor cells stopped multiplying, and survival rates increased.
